ReviewF1000Research2021

Contribution of BCR-ABL molecular variants and leukemic stem cells in response and resistance to tyrosine kinase inhibitors: a review.

Mohammad Al HamadPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.